Free Trial
ASX:DVL

dorsaVi (DVL) Stock Price, News & Analysis

About dorsaVi Stock (ASX:DVL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$6.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for dorsaVi and its competitors with MarketBeat's FREE daily newsletter.

DVL Stock News Headlines

dorsaVi Launches AI-Powered Movement Analysis Platform
DorsaVi Eyes Blockchain for Enhanced Data Security
The mainstream media is wrong about AI — again
The mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And the media jumped to hasty conclusions. But as usual, there's one huge thing they missed.
DorsaVi Issues 50 Million Unquoted Options
DorsaVi Limited Announces New Securities Issuance
dorsaVi Limited Announces Director Resignation
dorsaVi Appoints New Chair Amid Leadership Changes
See More Headlines

DVL Stock Analysis - Frequently Asked Questions

dorsaVi Ltd (ASX:DVL) issued its earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share for the quarter. dorsaVi had a negative net margin of 95.66% and a negative trailing twelve-month return on equity of 102.89%.

Based on aggregate information from My MarketBeat watchlists, some other companies that dorsaVi investors own include Myriad Genetics (MYGN), VMware (VMW), Akers Biosciences (AKER), Alder Biopharmaceuticals (ALDR), Argos Therapeutics (ARGSQ), Aramark (ARMK) and Bellerophon Therapeutics (BLPH).

Company Calendar

Last Earnings
2/28/2019
Today
7/01/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Scientific & Technical Instruments
Sub-Industry
N/A
Current Symbol
ASX:DVL
CIK
N/A
Fax
N/A
Employees
34
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$1.25 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$1.30 million
Price / Cash Flow
1.71
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$6.58 million
Optionable
Not Optionable
Beta
1.24
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (ASX:DVL) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners